Clinical Trial Update: Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on the efficacy of platinum-based chemotherapy in platinum-resistant ovarian cancer across Phase 2 and Phase 3 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brca1 Mutation
• Brca2 Mutation
• Ovarian Cancer
• Ovarian Neoplasms
• Serous Adenocarcinoma

Snippet

Sponsor: Blokhin's Russian Cancer Research Center | Conditions: Ovarian Cancer, Ovarian Neoplasms | Phase 2, Phase 3 | Status: UNKNOWN